Panacea Biotec has received a long-term supply order from UNICEF. The order is for bivalent oral polio vaccines. It is valued at USD 35.65 ...

In a written reply to a question in the Lok Sabha from Congress member Rahul Gandhi and TMC's Mala Roy, Minister of State for Health Bharat...

Pending conditional regulatory approvals in India, BE expects to commence product launch of Corbevax later this year.

While India is looking to import oxygen from abroad as the union health ministry had said last week, official sources said China was not am...

In a communique to Union Health Secretary Rajesh Bhushan on Tuesday, the Director of Government and Regulatory Affairs at the Pune-based Se...

Stelis' pact with the Russian Direct Investment Fund (RDIF) follows similar deals struck by Indian pharmaceutical firms Gland Pharma and He...

Canada has an agreement with AZ to receive 20 million doses. The approval to Verity Pharmaceuticals Inc./Serum Institute of India product h...

Several countries around the world have expressed strong interest in Covaxin and the company was fully committed to ensuring supplies promp...

Canada has not yet signed a procurement agreement with Serum Institute of India (SII) for the supply of the AstraZeneca-University of Oxfor...

The Novavax vaccine has shown 90% efficacy in phase 3 clinical trials in the UK that enrolled more than 15,000 participants aged 18-84 year...

Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and suppl...

The agreement includes transfer of manufacturing of the protein part of the vaccine, RTS,S/AS01, while GSK will continue to supply Bharat B...

Responding to a question during a press briefing on Tuesday, Union Health Secretary Rajesh Bushan said, "The Union government has not banne...

U.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses ...

The Serum Institute of India (SII) will buy the vaccine components from Novavax and the two companies will equally split the revenue from t...

Cipla said it had agreed to an exclusive deal with Serum Institute to supply vaccines to South Africa, adding a new market to their partner...

HLL Biotech has entered into a long-term supply and technology licence agreement with the Institute of Immunology, Zagreb, Croatia.